Literature DB >> 18535830

Extramammary Paget's disease in Korea: its association with gastrointestinal neoplasms.

Sang Nam Yoon1, In Ja Park, Hee Cheol Kim, Chang Sik Yu, Mi Woo Lee, Jai Kyoung Koh, Jin Wou Kim, Young Soo Park, Jin Cheon Kim.   

Abstract

BACKGROUND: Extramammary Paget's disease (EMPD) most commonly occurs in the perineal and genital areas of elderly people. The current treatment of choice is adequate surgical excision.
MATERIALS AND METHODS: Between 1990 and 2007, 28 patients (27 men and one woman) with EMPD were treated at Asan Medical Center, Seoul, Korea, by wide local excision (WLE) with a 2- to 3-cm normal skin margin. "Carcinoma in situ" (CIS) was defined as confinement of Paget cells to the epithelium, whereas "invasive carcinoma" was defined as infiltration of Paget cells into more than dermal connective tissue.
RESULTS: Of the 28 lesions, 21 (75%) were located in the penoscrotal area. Six (21.4%) patients had associated gastrointestinal neoplasms, three with associated gastrointestinal malignancies and four with synchronous colorectal adenomas, including one with both. Surgical procedures included WLE with primary repair in 13 patients (46.4%), WLE with skin graft in 12 (42.9%), WLE with skin graft and Gracilis muscle transposition in two (7.1%), and combined abdominoperineal resection and distal gastrectomy in one (3.6%). Four patients (14.3%) also underwent inguinal lymph node dissection, with three found to have lymph node metastases. Of 11 patients with invasive carcinoma, three (27.3%) had lymph node metastases, compared with none of 17 patients with CIS. Patients with lymph node metastases showed a significantly lower disease-specific survival rate (P = 0.008). Patients with invasive carcinoma tended to have a lower disease-specific survival rate (P = 0.087).
CONCLUSIONS: EMPD in Korea showed an absolute male predominance and an association with gastrointestinal neoplasms. Lymph node metastasis significantly affected, and depth of invasion tended to affect, disease-specific survival rate.

Entities:  

Mesh:

Year:  2008        PMID: 18535830     DOI: 10.1007/s00384-008-0499-8

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  27 in total

1.  Anogenital (extramammary) Paget's disease. A clinicopathological study.

Authors:  E B HELWIG; J H GRAHAM
Journal:  Cancer       Date:  1963-03       Impact factor: 6.860

2.  Extramammary Paget's disease of the genitalia with clinically clear margins can be adequately resected with 1 cm margin.

Authors:  Y Murata; K Kumano
Journal:  Eur J Dermatol       Date:  2005 May-Jun       Impact factor: 3.328

3.  Cells of extramammary Paget's disease express cytokeratins different from those of epidermal cells.

Authors:  I Moll; R Moll
Journal:  J Invest Dermatol       Date:  1985-01       Impact factor: 8.551

4.  Extramammary Paget's cells: further evidence of sweat gland derivation.

Authors:  H Hamm; T M Vroom; B M Czarnetzki
Journal:  J Am Acad Dermatol       Date:  1986-12       Impact factor: 11.527

Review 5.  Extramammary Paget's disease.

Authors:  W R Heymann
Journal:  Clin Dermatol       Date:  1993 Jan-Mar       Impact factor: 3.541

6.  Immunohistology is valuable in distinguishing between Paget's disease, Bowen's disease and superficial spreading malignant melanoma.

Authors:  W Reed; B R Oppedal; T Eeg Larsen
Journal:  Histopathology       Date:  1990-06       Impact factor: 5.087

7.  Paget's disease of the anus: a clinicopathological study.

Authors:  N C Armitage; J R Jass; P I Richman; J P Thomson; R K Phillips
Journal:  Br J Surg       Date:  1989-01       Impact factor: 6.939

Review 8.  Immunohistochemical markers of melanocytic tumors.

Authors:  Hadi Yaziji; Allen M Gown
Journal:  Int J Surg Pathol       Date:  2003-01       Impact factor: 1.271

9.  Penoscrotal extramammary Paget's disease: a review of 33 cases in a 20-year experience.

Authors:  Yung-Lung Lai; Wen-Guei Yang; Pei-Kwei Tsay; Hsueh Swei; Shiow-Shuh Chuang; Chou-Jin Wen
Journal:  Plast Reconstr Surg       Date:  2003-09-15       Impact factor: 4.730

10.  Immunohistochemical stains in extramammary Paget's disease.

Authors:  K F Helm; J R Goellner; M S Peters
Journal:  Am J Dermatopathol       Date:  1992-10       Impact factor: 1.533

View more
  7 in total

Review 1.  Prognostic Factors of Extramammary Paget's Disease.

Authors:  Naohito Hatta
Journal:  Curr Treat Options Oncol       Date:  2018-08-15

Review 2.  Perianal Paget's disease: presentation of six cases and literature review.

Authors:  Annamaria Minicozzi; Giuseppe Borzellino; Rostand Momo; Francesca Steccanella; Federica Pitoni; Giovanni de Manzoni
Journal:  Int J Colorectal Dis       Date:  2009-08-26       Impact factor: 2.571

3.  Penoscrotal extramammary Paget's disease: surgical techniques and follow-up experiences with thirty patients.

Authors:  Qi Chen; Yan-Bo Chen; Zhong Wang; Zhi-Kang Cai; Yu-Bing Peng; Da-Chao Zheng; Li-Ming Ma; Hai-Jun Yao; Juan Zhou
Journal:  Asian J Androl       Date:  2013-05-20       Impact factor: 3.285

4.  Perianal Paget's disease as spread from non-invasive colorectal adenomas.

Authors:  Danielle Hutchings; Annika Windon; Naziheh Assarzadegan; Kevan J Salimian; Lysandra Voltaggio; Elizabeth A Montgomery
Journal:  Histopathology       Date:  2020-09-23       Impact factor: 7.778

5.  Extramammary Paget's Disease of Anal Canal Associated With Rectal Adenoma Without Invasive Carcinoma.

Authors:  Vaibhav Chumbalkar; Timothy A Jennings; Sanaz Ainechi; Edward C Lee; Hwajeong Lee
Journal:  Gastroenterology Res       Date:  2016-12-23

6.  Extramammary paget disease: minimal surgical therapy.

Authors:  Ji-Hyun Choi; Mihn-Sook Jue; Eun-Jung Kim; Ok-Ja Joh; Kye-Yong Song; Hyang-Joon Park
Journal:  Ann Dermatol       Date:  2013-05-10       Impact factor: 1.444

7.  Local Excision of a Mucinous Adenocarcinoma of the Anal Margin (Extramammary Paget's Disease) and Reconstruction with a Bilateral V-Y Flap.

Authors:  Michele Pagnanelli; Paola De Nardi; Stefano Martella; Luca Caruso; Riccardo Rosati
Journal:  Case Rep Surg       Date:  2019-12-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.